| Code | 7697E | ||||||||||
| MA number | 44/0267/24-S | ||||||||||
| Product Form: | sol inj 6x3 ml/1,32 mg (liek.inj.skl) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | EVER Valinject GmbH, Austria | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 10.10.2024 |
| Validity: | 10.10.2029 |
| SPC: |
SPC_Eribulin EVER Pharma 0,44 mg_ml injekčný roztok_10 2024.pdf
|
| PIL: |
PIL_Eribulin EVER Pharma 0,44 mg_ml injekčný roztok_10 2024.pdf
|
| Safety feature | Yes |
| Data update: | 20.11.2024 |
